Drug and drug math

Card Set Information

Author:
Anonymous
ID:
131204
Filename:
Drug and drug math
Updated:
2012-01-28 15:56:56
Tags:
brittany math cards
Folders:

Description:
Np2 Math
Show Answers:

Home > Flashcards > Print Preview

The flashcards below were created by user Anonymous on FreezingBlue Flashcards. What would you like to do?


  1. Bumetanide (Bumex)
    Furosemide (Lasix)
    Torsemide (Demadex)
    Loop Diuretic
  2. Amikacin-
    Gentamicin
    Kanamycin
    Neomycin
    Streptomycin
    Tobramycin
    Vancomycin
    Aminoglycoside
  3. Cimetidine
    Famotidine
    Nizatidine
    Ranitidine
    H2 blocker
  4. Carvedilol
    Labetalol
    Nadolol
    Propranolol
    Metoprolol
    Beta blocker-
  5. Catopril
    Enalapril
    LIsinopril
    Benazepril
    ACE inhibitor
  6. What classification is Protonix
    anti-ulcer/ Proton pump inhibitor
  7. Intermediate acting insulins
    NPH- Humulin N, Nolvolin N, Relion N
  8. Rapid acting
    lispro-Humalog, aspart- Novolog, glulisine- Apidra
  9. Regular insulin
    Humulin R, Novolin R, ReliOn R
  10. Long Acting insulin
    glargine-Lantus, determir-Levemir
  11. When mixing insulins, what do you always end with?
    ALWAYS END WITH INTERMEDIATE ACTING WHEN MIXING (cloudy)
  12. Gauge and length for ID
    ID- 25,26 … 3/8, ½, 5/8… 10*-15*
  13. Gauge and length for SubQ
    SubQ- 23,25,26… 3/8, ½ , 5/8… 45*-90*
  14. Gauge and length for IM
    IM- 19,20,21,22… 1, 1 ½ , 2… 90o
  15. IV calculations for gtts/ min and mL per hour
    • A. Amount of fluid/ Hours= mL/hr
    • B. mL/hr X gtts/mL / 60 min= gtts/min
  16. 1gr=___ mg
    60 or 65
  17. 1 G=__gr
    15
  18. 1L=__oz
    32
  19. 1mL=___gtts
    15
  20. Aminoglycoside
    Classification:
    Anti-infective
  21. Aminoglycoside
    Indication:
    serious gram negative infections, management of TB
  22. Aminoglycoside
    Action:
    Inhibits protein synthesis of bacteria
  23. Aminoglycoside
    Nursing Implications
    • Evaluate eighth cranial nerve function by audiometry before and throughout therapy. Hearing loss is usually in the high-frequency range. Prompt recognition and intervention are essential in preventing permanent damage.
    • Also monitor for vestibular dysfunction (vertigo, ataxia, nausea, vomiting)
    • Assess I &O and daily weights for renal function.
    • Assess signs for super infection (fever, upper respiratory infection, vaginal itching or discharge, increasing malaise, diarrhea)
  24. Aminoglycoside
    Blood/lab work (overdose or toxicity)
    Monitor blood levels periodically during therapy. Timing of blood levels is important in interpreting results. Draw blood peak levels 1hr after IM injection and 30min after a 30 min IV infusion is completed. Draw trough levels just before next dose.
  25. Ace Inhibitor
    classification
    Antihypertensive
  26. Ace Inhibitor
    Indication:
    • Hypertension
    • CHF
    • Slowed progression of left ventricular dysfunction
    • Decreased progression of diabetic nephropathy
  27. Ace Inhibitor
    Action:
    Blocks Angiotensin I to vasoconstrictor Angiotensin II. Increases plasma renin and decreases aldosterone.
  28. Ace Inhibitor
    Nursing Implications
    • Montior pulse and BP frequently during first dose adjustment.
    • Monitor for s/s of angioedema (dyspnea, facial swelling)
    • Monitor weights and assess for fluid overfload
  29. Ace Inhibitor
    Blood/lab monitoring
    Monitor BUN, Creatine and electrolyte levels periodically. Monitor CBC with differential prior to initiation of therapy, every 2 wks for the first 3 months and periodically for up to 1 year in patients at risk for neutropenia (pts with renal impairment or collagen-vascular disease) or at first sign of infection. Discontinue therapy if neutrophil count is <1000/mm3
  30. Beta Blocker
    Classification
    • Antihypertensives
    • Antianginals
  31. Beta Blocker
    Indication
    • Hypertensive
    • Prevention of MI
    • Management of heart failure due to ichemic, hypertensive or cardiomyopathic origan.
  32. Beta Blocker
    Action
    Blocks stimulation of beta (myocardial) adrenergic receptors. Does NOT block beta2 receptors.
  33. Beta Blocker
    Contraindications
    • Pulmonary Edema
    • Bradycardia
    • Uncompensated CHF
  34. Beta Blocker
    Nursing implications
    • Monitor BP and pulse frequently during dose adjustment period and periodically during therapy.
    • Monitor I&O, daily weight.
    • Assess patient routinely for evidence of fluid overload (peripheral edema, dyspnea, rales/crackles, fatigue, weight gain, jugular venous distention)
    • Patients may experience worsening of symptoms during initiation of therapy for CHF
  35. Beta Blocker
    Overdose and Toxicity
    Monitor patients receiving beta blockers for signs of overdose: bradycardia, severe dizziness or fainting, severe drowsiness, dyspnea, bluish fingernails or palms, seizures. Notify health care professional immediately if these signs occur. Montior vitals and ECG every 5-15 minutes during and for several hours after parenteral admin. If heart rate is <40 bpm, especially if cardiac output is also decreased, administer atropine 0.25-.5 mg IV. Take apical pulse prior to administering. If heart rate is <50 bpm or if arrhythmias occur, hold medication and notify doctor.
  36. Loop Diuretic
    Classification:
    Diuretic
  37. Loop diuretic
    Indication:
    Edema due to heart failure, hepatic impairment, renal disease, or hypertension
  38. Loop diuretic
    Action
    Inhibits reabsorption of Na+ and Cl- from loop of henle
  39. Loop diuretic
    Nursing implications
    • Montior daily weights
    • Monitor BP and location of any edema
    • Monitor patients taking digoxin for toxticity
    • Assess for tinnitus and hearig loss
  40. Proton-Pump Inibitor
    Classification
    Anti-ulcer agent
  41. Proton pump inhibitor
    Indication
    Erosive esophagitis associated with GERD. Decreases relapse rates of heartburn with GERD.
  42. Proton Pump Inhibitor
    Action
    Binds to an enzyme in the presence of acidic gaastric pH preventing final transport of H+ ions to gastric lumen
  43. Proton Pump Inhibitor
    Nursing Implications:
    May increase bleeding with warfarin. Assess for epigastric or abdominal pain and frank or occult blood in the stool, emesis, or gastric aspirate
  44. Histamine H2 Antagonists
    Classifications
    Anti-ulcer agents
  45. Histamine H2 Antagonists
    Indications
    • Short term treatment of duodenal ulcers and benign gastric ulcers.
    • Management of GERD.
    • Treatment of heartburn, acid indigestion, and sour stomach.
  46. Histamine H2 Antagonists
    Action:
    Inhibits the action of histamine at the H2 receptor site. Inhibits gastric acid secreation.
  47. Histamine H2 Antagonists
    Nursing Implications
    Assess for epigastric or abdominal pain, occult blood, emesis, assess geriatric patients for confusion
  48. Histamine H2 Antagonists
    overdose or toxicity
    Monitor CBC with differential periodically during therapy. May lead to increase levels and toxicity with benzodiazepines, some beta blockers, caffeine, calcium channel blockers, carbamazepine, cyclosporine, dofetilide, lidocaine, and MANY others..

What would you like to do?

Home > Flashcards > Print Preview